Literature DB >> 8233824

Methylphosphate cap structure increases the stability of 7SK, B2 and U6 small RNAs in Xenopus oocytes.

G Shumyatsky1, D Wright, R Reddy.   

Abstract

We studied the role of the methylphosphate cap structure in the stability and nucleocytoplasmic transport by microinjecting U6, 7SK and B2 RNAs into the Xenopus oocytes. In every case, the methylphosphate capped RNAs were 3 to 9 times more stable than the uncapped RNAs. When a methylphosphate cap structure was placed on human H1 RNA which is normally not capped, its stability was improved 2-7 fold. These data show that the methylphosphate cap enhances the stability of 7SK, B2, H1 and U6 RNAs. The methylphosphate-capped 7SK RNA was transported into the nucleus from cytoplasm, but remained in the nucleus when injected into the nucleus; in this respect, 7SK RNA exhibited properties previously shown for U6 RNA. Both U6 and 7SK RNAs with ppp on their 5' ends were transported from cytoplasm to the nucleus suggesting that the methylphosphate cap structure is not required for transport of these RNAs across the nuclear membrane.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8233824      PMCID: PMC331502          DOI: 10.1093/nar/21.20.4756

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  Gamma-monomethyl phosphate: a cap structure in spliceosomal U6 small nuclear RNA.

Authors:  R Singh; R Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  Structure and transcription of a human gene for H1 RNA, the RNA component of human RNase P.

Authors:  M Baer; T W Nilsen; C Costigan; S Altman
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

3.  RNA processing and ribonucleoprotein assembly studied in vivo by RNA transfection.

Authors:  A M Kleinschmidt; T Pederson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  The trimethylguanosine cap structure of U1 snRNA is a component of a bipartite nuclear targeting signal.

Authors:  J Hamm; E Darzynkiewicz; S M Tahara; I W Mattaj
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

5.  An essential signaling role for the m3G cap in the transport of U1 snRNP to the nucleus.

Authors:  U Fischer; R Lührmann
Journal:  Science       Date:  1990-08-17       Impact factor: 47.728

6.  Pathway of B1-Alu expression in microinjected oocytes: Xenopus laevis proteins associated with nuclear precursor and processed cytoplasmic RNAs.

Authors:  R Maraia; M Zasloff; P Plotz; S Adeniyi-Jones
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

7.  The in vitro transcription of the 7SK RNA gene by RNA polymerase III is dependent only on the presence of an upstream promoter.

Authors:  S Murphy; C Di Liegro; M Melli
Journal:  Cell       Date:  1987-10-09       Impact factor: 41.582

8.  Monomethylated cap structures facilitate RNA export from the nucleus.

Authors:  J Hamm; I W Mattaj
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

9.  An abundant U6 snRNP found in germ cells and embryos of Xenopus laevis.

Authors:  J Hamm; I W Mattaj
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

10.  Upstream regulatory elements are necessary and sufficient for transcription of a U6 RNA gene by RNA polymerase III.

Authors:  G Das; D Henning; D Wright; R Reddy
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  16 in total

1.  Adenovirus-mediated expression of a ribozyme to c-myb mRNA inhibits smooth muscle cell proliferation and neointima formation in vivo.

Authors:  D G Macejak; H Lin; S Webb; J Chase; K Jensen; T C Jarvis; J M Leiden; L Couture
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Effect of 3' terminal adenylic acid residue on the uridylation of human small RNAs in vitro and in frog oocytes.

Authors:  Y Chen; K Sinha; K Perumal; R Reddy
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

3.  Inhibition of translation of mRNAs containing gamma-monomethylphosphate cap structure in frog oocytes and in mammalian cells.

Authors:  Y Chen; K Perumal; R Reddy
Journal:  Gene Expr       Date:  2000

Review 4.  RNA therapy: Are we using the right molecules?

Authors:  Ai-Ming Yu; Chao Jian; Allan H Yu; Mei-Juan Tu
Journal:  Pharmacol Ther       Date:  2018-12-04       Impact factor: 12.310

5.  Methylphosphate cap structure in small RNAs reduces the affinity of RNAs to La protein.

Authors:  Rajat Bhattacharya; Karthika Perumal; Krishna Sinha; Richard Maraia; Ram Reddy
Journal:  Gene Expr       Date:  2002

Review 6.  Conserved and divergent features of the structure and function of La and La-related proteins (LARPs).

Authors:  Mark A Bayfield; Ruiqing Yang; Richard J Maraia
Journal:  Biochim Biophys Acta       Date:  2010-02-02

7.  In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulation.

Authors:  S B Noonberg; G K Scott; M R Garovoy; C C Benz; C A Hunt
Journal:  Nucleic Acids Res       Date:  1994-07-25       Impact factor: 16.971

8.  Capping signals correspond to the 5' end in four eukaryotic small RNAs containing gamma-monomethylphosphate cap structure.

Authors:  G Shumyatsky; S Shimba; R Reddy
Journal:  Gene Expr       Date:  1994

9.  Accurate and efficient N-6-adenosine methylation in spliceosomal U6 small nuclear RNA by HeLa cell extract in vitro.

Authors:  S Shimba; J A Bokar; F Rottman; R Reddy
Journal:  Nucleic Acids Res       Date:  1995-07-11       Impact factor: 16.971

10.  miR-22-5p and miR-29a-5p Are Reliable Reference Genes for Analyzing Extracellular Vesicle-Associated miRNAs in Adipose-Derived Mesenchymal Stem Cells and Are Stable under Inflammatory Priming Mimicking Osteoarthritis Condition.

Authors:  Enrico Ragni; Carlotta Perucca Orfei; Paola De Luca; Marco Viganò; Alessandra Colombini; Gaia Lugano; Valentina Bollati; Laura de Girolamo
Journal:  Stem Cell Rev Rep       Date:  2019-10       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.